Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Meisel

Showing results (241-250 of 311) with videos related to

Pageof 32
Sort By:
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 25, 2019
An exploratory investigation of brain collateral circulation plasticity after cerebral ischemia in two experimental C57BL/6 mouse modelsMarco Foddis, Katarzyna Winek, Kajetan Bentele, et al.
European Journal of Neurology|September 12, 2022
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisalAndreas Meisel, Fulvio Baggi, Anthony Behin, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 24, 2007
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humansKarl Georg Haeusler, Wolf U H Schmidt, Fabian Föhring, et al.
JCI Insight|May 25, 2023
Eculizumab treatment alters the proteometabolome beyond the inhibition of complementChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.
Annals of Clinical and Translational Neurology|November 20, 2025
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and EculizumabLea Gerischer, Frauke Stascheit, Maximilian Mönch, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2020
Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockadeKatarzyna Winek, Sebastian Lobentanzer, Bettina Nadorp, et al.
European Journal of Neurology|January 24, 2023
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal"Andreas Meisel, Fulvio Baggi, Anthony Behin, et al.
Ebiomedicine|August 2, 2025
Artificial intelligence for prediction of atrial fibrillation in the stroke unit: a retrospective derivation validation cohort studyMaximilian Schoels, Laura Krumm, Alexander Nelde, et al.
Muscle & Nerve|February 8, 2016
Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMSShin J Oh, Natalya Shcherbakova, Anna Kostera-Pruszczyk, et al.
European Journal of Neurology|November 5, 2025
Robotic Extended Thymectomy in Late-Onset Myasthenia Gravis: A 21-Year Retrospective Cohort Study of 172 PatientsLuyu Huang, Feng Li, Zhongmin Li, et al.
Pageof 32

Showing results (241-250 of 311) with videos related to

Sort By:
Pageof 32
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 25, 2019
An exploratory investigation of brain collateral circulation plasticity after cerebral ischemia in two experimental C57BL/6 mouse modelsMarco Foddis, Katarzyna Winek, Kajetan Bentele, et al.
European Journal of Neurology|September 12, 2022
Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisalAndreas Meisel, Fulvio Baggi, Anthony Behin, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 24, 2007
Cellular immunodepression preceding infectious complications after acute ischemic stroke in humansKarl Georg Haeusler, Wolf U H Schmidt, Fabian Föhring, et al.
JCI Insight|May 25, 2023
Eculizumab treatment alters the proteometabolome beyond the inhibition of complementChristopher Nelke, Christina B Schroeter, Frauke Stascheit, et al.
Annals of Clinical and Translational Neurology|November 20, 2025
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and EculizumabLea Gerischer, Frauke Stascheit, Maximilian Mönch, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2020
Transfer RNA fragments replace microRNA regulators of the cholinergic poststroke immune blockadeKatarzyna Winek, Sebastian Lobentanzer, Bettina Nadorp, et al.
European Journal of Neurology|January 24, 2023
Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal"Andreas Meisel, Fulvio Baggi, Anthony Behin, et al.
Ebiomedicine|August 2, 2025
Artificial intelligence for prediction of atrial fibrillation in the stroke unit: a retrospective derivation validation cohort studyMaximilian Schoels, Laura Krumm, Alexander Nelde, et al.
Muscle & Nerve|February 8, 2016
Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMSShin J Oh, Natalya Shcherbakova, Anna Kostera-Pruszczyk, et al.
European Journal of Neurology|November 5, 2025
Robotic Extended Thymectomy in Late-Onset Myasthenia Gravis: A 21-Year Retrospective Cohort Study of 172 PatientsLuyu Huang, Feng Li, Zhongmin Li, et al.
Pageof 32